Cargando…
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
There is substantial evidence to suggest that complete tumor eradication relies on the effective elimination of cancer stem cells (CSCs). CSCs have been widely described as mediators of resistance to conventional therapies, including chemo- and radiotherapy, as well as of tumor metastasization and r...
Autores principales: | Ruiu, Roberto, Di Lorenzo, Antonino, Cavallo, Federica, Conti, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069673/ https://www.ncbi.nlm.nih.gov/pubmed/35530300 http://dx.doi.org/10.3389/fonc.2022.877384 |
Ejemplares similares
-
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
por: Salemme, Vincenzo, et al.
Publicado: (2021) -
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents
por: Conti, Laura, et al.
Publicado: (2016) -
Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer
por: Ruiu, Roberto, et al.
Publicado: (2021) -
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models
por: Barutello, Giuseppina, et al.
Publicado: (2022) -
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy
por: Di Lorenzo, Antonino, et al.
Publicado: (2022)